|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.97 CNY | +1.35% |
|
-1.89% | -3.93% |
Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 775.67 million. Revenue was CNY 775.67 million.
Net income was CNY 87.71 million. Basic earnings per share from continuing operations was CNY 0.3782. Diluted earnings per share from continuing operations was CNY 0.3559.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.93% | 376M | |
| +9.85% | 72.5B | |
| +13.08% | 9.11B | |
| -12.85% | 5.07B | |
| +60.16% | 5.01B | |
| +1.60% | 3.85B | |
| -19.20% | 2.46B | |
| +18.65% | 2.44B | |
| +24.62% | 2.27B | |
| -27.46% | 2.26B |
GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD. 
